ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Spiriva® Respimat® (wiederverwendbar):Boehringer Ingelheim (Schweiz) GmbH
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
R03BB04 - Tiotropium BromideATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R03 - Drugs for Obstructive Airway Diseases
 
R03B - Other Drugs for Obstructive Airway Diseases, Inhalants

This group comprises all drugs for obstructive airway diseases for inhalation excl. adrenergics (R03A).

See comment under R03A.

R03BB - Anticholinergics

Combinations with adrenergics are classified in R03AL.
The combination of tiotropium bromide and ciclosonide is classified in R03BB54.

The DDDs are based on the maintenance treatment of asthma.
The DDDs for tiotropium bromide and umeclidinium bromide are based on treatment of COPD (Chronic Obstructive Pulmonary Disease).
The DDD for tiotropium bromide inhalation powder is based on tiotropium, delivered dose.
The DDD for aclidinium bromide inhalation powder is based on aclidinium, delivered dose.
The DDD for glycopyrronium bromide inhalation powder is based on glycopyrronium, delivered dose.
The DDD for umeclidinium bromide inhalation powder is based on umeclidinium, delivered dose.

R03BB04 - Tiotropium Bromide
StärkeAdm.RouteNote
   
   
 "Expressed as tiotropium, delivered dose
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home